AMD
SILO
New toy, bigger sandbox
Silo Pharma’s wholly owned subsidiary, QwikAgents, just got into AMD’s AI Developer Program. Translation: more cloud credits, more tools, more training, and a bigger developer network to lean on while it tries to turn its AI agent platform into something people actually use.
Why investors care
This isn’t a revenue deal or a flashy merger. But for a developmental-stage company like Silo, access to a heavyweight chipmaker’s ecosystem can make the platform look more credible — and possibly more buildable. The market even gave the stock a quick pop before reality came back in and the shares faded into the red.
What QwikAgents is trying to be
The platform is aiming at a pretty crowded but very buzzy lane:
- persistent AI agents for individuals, developers, and businesses
- blank agents now, more purpose-built agents later
- use cases like research, content generation, scheduling, coding, browser automation, and workflow automation
Silo says starter plans could begin at $14 a month, with more robust infrastructure for heavier workloads. In other words: it’s trying to be the Swiss Army knife of AI agents, not just another shiny demo.
Big picture
For Silo Pharma, the AI story is now a real side quest next to its biotech pipeline. If QwikAgents can actually scale, AMD’s program could help it move faster — but investors should still remember that “partnered with” is not the same thing as “making money.”